title: DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives.
abstract: Cytotoxic effects and topoisomerase II-mediated DNA breaks induced in vitro by ellipticine derivatives were examined in connection with 1H NMR and circular dichroism (CD) studies on molecular structures and interactions of drugs with DNA. The compounds included four 9-hydroxyellipticine and two 7-hydroxyisoellipticine derivatives. Structure-activity relationships indicated that a change in nitrogen atom position in the pyridinic ring greatly affected drug effects both on topoisomerase II action and cytotoxicity to L1210 cells. The four 9-hydroxyellipticine derivatives yielded bell-shaped curves in in vitro topoisomerase II-mediated DNA break assays, whereas the two 7-hydroxyisoellipticine derivatives demonstrated an almost linear increase at the same concentration (0-10 microM). In both cases, the intensity of cleavage was modulated by the position and the degree of methylation on the pyridinic ring, and results were correlated with cytotoxic activity expressed as the in vitro ID50 values for L1210 leukemia cells. 1H NMR experiments performed on free drug molecules in solution revealed that the two protons (alpha and beta) contiguous to the biologically important hydroxy group were sensitive to changes in electron distribution produced by the distant chemical modifications and methylations of the pyridinic ring. A linear relationship was observed between the differences in chemical shifts of alpha and beta protons (delta delta alpha-beta) versus ID50 values. CD experiments indicated that, at weak ionic strength I = 0.02 and at pH 7, drugs interact with the poly[d(A-T)] duplex according to a "three-mode binding model" which is governed by the drug structure and the drug to DNA ratio. The intercalation mode was related to the induction of topoisomerase II-mediated DNA cleavage, while the external binding mode consecutive to intercalation was related to cleavage suppression. These two modes concerned the good intercalators 9-hydroxyellipticines. The third was found for the weak intercalators 7-hydroxyisoellipticines and was characterized by self-stacked molecules bound "outside" DNA, presumably in the minor groove. Ligands either could be intercalated partially or linked at the edge of bases with a small number of molecules filling intercalation sites, for the second alternative. In addition to having different binding modes, 9-hydroxyellipticines were better inducers of DNA distortions than 7-hydroxyisoellipticines. The incidence of the drug binding modes on DNA-topoisomerase II recognition was discussed in connection with the in vitro cytotoxic activity exhibited by the drugs.
authors.affiliation: Institut Gustave Roussy, URA 147 Centre National de la Recherche Scientifique, U 140 Institut National de la Santé et de la Recherche Médicale, Villejuit, France.
authors.forename: M
authors.initials: M
authors.lastname: Monnot
authors.forename: O
authors.initials: O
authors.lastname: Mauffret
authors.forename: V
authors.initials: V
authors.lastname: Simon
authors.forename: E
authors.initials: E
authors.lastname: Lescot
authors.forename: B
authors.initials: B
authors.lastname: Psaume
authors.forename: J M
authors.initials: JM
authors.lastname: Saucier
authors.forename: M
authors.initials: M
authors.lastname: Charra
authors.forename: J
authors.initials: J
authors.lastname: Belehradek
authors.forename: S
authors.initials: S
authors.lastname: Fermandjian
mesh_terms: D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D002942:Circular Dichroism; D004247:DNA / Q000737:chemistry* / Q000378:metabolism; D004249:DNA Damage; D004250:DNA Topoisomerases, Type II / Q000378:metabolism*; D004611:Ellipticines / Q000737:chemistry* / Q000633:toxicity; D066298:In Vitro Techniques; D007364:Intercalating Agents / Q000737:chemistry; D007939:Leukemia L1210; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship
chemical_list: D004611:Ellipticines; D007364:Intercalating Agents; C034192:ellipticine; D004247:DNA; D004250:DNA Topoisomerases, Type II